A consortium of 14 pharmaceutical companies will now use those samples and start the largest proteomics study to date.

For the first time, researchers have reported a 3D metal-organic framework (MOF) that can conduct both electrons and protons ...

Roche has licensed an antibody-drug conjugate (ADC) designed to treat advanced small-cell lung cancer from China-based Innovent Biologics for $80 million up front and up to $1 billion in milestone ...